Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-01-30, Stock:JNJ, The news for the past five days is as follows:
2020-01-23: NEWS1: Gilead, Bristol-Myers Pumped More Into R&D Than Shareholder Enrichments.NEWS2: Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?.NEWS3: US Indexes End Mostly Flat Wednesday.NEWS4: This Medical Giant Just Topped An Entry — Should You Buy ABT Stock Now?.NEWS5: JNJ Stock Recently Hit A Fresh High — Is It Time To Buy Shares?.NEWS6: Johnson & Johnson Sold a Hot Biotech Stock.
2020-01-24: NEWS1: Johnson & Johnson Stock at Cusp of Historic Breakout.NEWS2: Top Stock Research Reports for Intel, Boeing & Blackstone.NEWS3: Pharma Stock Roundup: J&J's Mixed Q4, Roche & Novartis' New Drugs Approval in EU.NEWS4: J&J's Stelara Gets EU Nod for Plaque Psoriasis in Children.
2020-01-27: NEWS1:  J&J CEO testifies: 'I did not read all the documents'.NEWS2: CDC officials say coronavirus is similar to SARS, no new U.S. cases reported.NEWS3: Your 6-point plan to navigating a choppy stock market.NEWS4: J&J CEO questioned over stock sale ahead of story on asbestos in Baby Powder.NEWS5: J&J CEO questioned over stock sale ahead of story on asbestos in Baby Powder.NEWS6: Johnson & Johnson Is 'Confident' In Ability To Treat Coronavirus, But Vaccine Could Take Time.NEWS7: Coronavirus Ends Weekly Winning Streaks.NEWS8: J&J CEO to testify at trial for first time on Baby Powder risks.NEWS9: J&J Confident of Development of Coronavirus Vaccine; Credit Suisse Boosts Price Target.
2020-01-28: NEWS1: China's coronavirus outbreak: Here's what happened on Tuesday.NEWS2: Johnson & Johnson Is the Quintessential Recession-Proof Company.NEWS3: UK healthcare cost agency rejects J&J's nasal spray for depression.
2020-01-29: NEWS1: Coronavirus update: Vaccine expected in Phase 1 trial within months, WHO to reconvene on Thursday.NEWS2: Johnson & Johnson working on vaccine for coronavirus.NEWS3: How Microsoft, PepsiCo and other solid plays helped this fund manager ride out a bumpy decade.NEWS4: Alkermes' (ALKS) NDA for ALKS 3831 Accepted by FDA for Review.NEWS5: J&J begins development of coronavirus vaccine.NEWS6: Johnson & Johnson starts developing vaccine for coronavirus.NEWS7: Big Drug/Biotech Stock Earnings on Jan 30: BIIB, ALXN & More.NEWS8: Johnson & Johnson Launches Multi-Pronged Response to Coronavirus Global Public Health Threat.NEWS9: Johnson & Johnson Says It's Working on a Coronavirus Vaccine.

Answer: Decrease